Renal Cell Cancer Update

Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPOvarian23/Part3).

Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPAMLMDS23/Part3).

Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayHER2PanTumor23/1Gyn).

Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/BTC).

Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer, moderated by Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Lung).

Featuring a discussion on optimizing the management of gastroesophageal cancers with Dr Samuel J Klempner, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPGastroesophageal23/Part3).

Dr Aditya Bardia from Massachusetts General Hospital and Dr Sara M Tolaney from the Dana-Farber Cancer Institute, both in Boston, Massachusetts, discuss key presentations on the management of breast cancer from the 2023 ESMO Congress, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Breast).

Dr Richard Penson from Massachusetts General Hospital in Boston, Massachusetts and Dr Krishnansu Tewari from the University of California, Irvine, discuss updated data from the 2023 ESMO Congress on optimal management approaches for gynecologic cancers. CME information and select publications here (https://www.researchtopractice.com/PostESMO23/Gyn).

Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPGastroesophageal23/Part2).

Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (http://www.ResearchToPractice.com/MTPAMLMDS23/Part2).

Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (http://www.ResearchToPractice.com/MTPOvarian23/Part2)

Dr Nikhil Khushalani from the Moffitt Cancer Center in Tampa, Florida, and Dr Anna Pavlick from the Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss available and novel treatment strategies for cutaneous squamous cell carcinoma and basal cell carcinoma. CME information and select publications here (https://researchtopractice.com/InsidetheIssue2023/NonmelanomaSkin)

Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPGastroesophageal23/Part1)

Dr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches for patients with acute myeloid leukemia and myelodysplastic syndromes. CME information and select publications here (https://www.researchtopractice.com/MTPAMLMDS23/Part1)

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma. CME information and select publications here (https://www.researchtopractice.com/RRMCL2023)

Dr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPostConf23/MM)

Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small cell lung cancer. CME information and select publications here (https://researchtopractice.com/InsidetheIssue2023/NSCLC)

Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment strategies for pancreatic cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodaymPancreatic23)

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificNHL23)

Dr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and investigational treatment strategies for the management of ovarian cancer. CME information and select publications here (https://www.researchtopractice.com/MTPOvarian23/Part1)